Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: A cross-sectional analysis of the effect of kidney alone and kidney-pancreas transplantation

Diabetes Care

Volumn 30, Issue 3, 2007, Pages 597-603

  Fiorina, Paolo ^a,b   Perseghin, Gianluca ^a,c   De Cobelli, Francesco ^a   Gremizzi, Chiara ^a   Petrelli, Alessandra ^a   Monti, Lucilla ^a   Maffi, Paola ^a   Luzi, Livio ^a,c   Secchi, Antonio ^a,d   Del Maschio, Alessandro ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ADENOSINE TRIPHOSPHATE; CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHATE; PREDNISONE; TACROLIMUS; THROMBOXANE B2; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; ENERGY METABOLISM; GLUCOSE METABOLISM; HIGH ENERGY PHOSPHATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PANCREAS TRANSPLANTATION; LIPID METABOLISM; MICROALBUMINURIA; NEPHROTOXICITY; PANCREAS TRANSPLANTATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY;

ADULT; BLOOD PRESSURE; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOSUPPRESSION; INSULIN-SECRETING CELLS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PANCREAS TRANSPLANTATION; PHOSPHATES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33847642892     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1324     Document Type: Article

References (34)

1. Harlan WR Jr, Holden KR, Williams GM, Hume DM: Proteinuria and nephrotic syndrome associated with chronic rejection of kidney transplants. N Engl J Med 277:769-776, 1967
2. Colvin RB: Chronic allograft nephropathy. N Engl J Med 349:2288-2290, 2003
3. Chandraker A, Azuma H, Nadeau K, Carpenter CB, Tilney NL, Hancock WW, Sayegh MH: Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest 101:2309-2318, 1998
4. De Cobelli F, Fiorina P, Perseghin G, Magnone M, Venturini M, Zerbini G, Zanello A, Mazzolari G, Monti L, Di Carlo V, Secchi A, Del Maschio A: L-arginine-induced vasodilation of the renal vasculature is preserved in uremic type 1 diabetic patients after kidney and pancreas but not after kidney-alone transplantation. Diabetes Care 27:947-954, 2004
5. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 349:2326-2333, 2003
6. Klemm A, Rzanny R, Funfstuck R, Werner W, Schibert J, Kaiser WA, Stein G: 31P-magnetic resonance spectroscopy (31P-31P-MRS) of human allografts after renal transplantation. Nephrol Dial Transplant 13:3147-3152, 1998
7. Geisinger MA, Risius B, Jordan ML, Zelch MG, Novick AC, George CR: Magnetic resonance imaging of renal transplants. AJR Am J Roentgenol 143:1229-1234, 1984
8. Beckmann N, Hof RP, Rudin M: The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man. NMR Biomed 13:329-348, 2000
9. Shapiro JI, Haug CE, Weil R 3rd, Chan L: 31P nuclear magnetic resonance study of acute renal dysfunction in rat kidney transplants. Magn Reson Med 5:346-352, 1987
10. Seto K, Ikehira H, Obata T, Sakamoto K, Yamada K, Kshiwabara H, Yokoyama T, Tanada S: Long-term assessment of post-transplant renal prognosis with 31 P magnetic resonance spectroscopy. Transplantation 72:627-630, 2001
11. Bunnapradist S, Cho YW, Cecka JM, Wilkinson A, Danovitch GM: Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol 14:208-213, 2003
12. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69-75, 1998
13. Fiorina P, Venturini M, Folli F, Losio C, Maffi P, Placidi C, La Rosa S, Orsenigo E, Socci C, Capella C, Del Maschio A, Secchi A: Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet co-transplantation. Diabetes Care 28:1303-1310, 2005
14. Bank N, Lahorra MA, Aynedjian HS, Schlondorff D: Vasoregulatory hormones and the hyperfiltration of diabetes. Am J Physiol 254:F202-209, 1988
15. Remuzzi G, FitzGerald GA, Patrono C: Thromboxane synthesis and action within the kidney. Kidney Int 41:1483-1493, 1992
16. Gambardella S, Andreani D, Cancelli A, Di Mario U, Cardamone I, Stirati G, Cinotti GA, Pugliese F: Renal hemodynamics and urinary excretion of 6-ketoprostaglandin F1 alpha and thromboxane B2 in newly diagnosed type 1 diabetic patients. Diabetes 37:1044-1048, 1988
17. Castello L, Sainaghi PP, Bergamasco L, Letizia C, Bartoli E: Pathways of glomerular toxicity of cyclosporine-A: an "in vitro" study. J Physiol Pharmacol 56:649-660, 2005
18. Remuzzi G, Bertani T: Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 13:261-272, 1989
19. Heering P, Degenhardt S, Grabensee B: Tubular dysfunction following kidney transplantation. Nephron 74:501-511, 1996
20. Goodall T, Kind CN, Hammond TG: FK506-induced endothelin release by cultured rat mesangial cells. J Cardiovasc Pharmacol 26 (Suppl. 3):S482-485, 1995
21. Kasiske BL, Gaston RS, Gourishankar S, Halloran PF, Matas AJ, Jeffery J, Rush D: Long-term deterioration of kidney allograft function. Am J Transplant 5:1405-1414, 2005
22. Monaco AP, Burke JF Jr, Ferguson RM, Halloran PF, Kahan BD, Light JA, Matas AJ, Solez K: Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion. Am J Kidney Dis 33:150-160, 1999
23. Coombes JD, Mreich E, Liddle C, Rangan GK: Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy. Kidney Int 68:2599-2607, 2005
24. Pelle G, Xu Y, Khoury N, Mougenot B, Rondeau E: Thrombotic microangiopathy in marginal kidneys after sirolimus use. Am J Kidney Dis 46:1124-1128, 2005
25. Daniel C, Renders L, Amann K, Schulze-Lohoff E, Hauser IA, Hugo C: Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat. Am J Transplant 5:2849-2861, 2005
26. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B: Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 5:2273-2280, 2005
27. Ninova D, Covarrubias M, Rea DJ, Park WD, Grande JP, Stegall MD: Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factorbeta1 and alpha-smooth muscle actin. Transplantation 78:338-344, 2004
28. Fiorina P, Folli F, Zerbini G, Maffi P, Gremizzi C, Di Carlo V, Socci C, Bertuzzi F, Kashgarian M, Secchi A: Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol 14:2150-2158, 2003
29. Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberg U, Burg M, Luft FC, Gwinner W, Haller H: The renal arterial resistance index and renal allograft survival. N Engl J Med 349:115-124, 2003
30. Heindel W, Kugel H, Wenzel F, Stippel D, Schmidt R, Lackner K: Localized 31P MR spectroscopy of the transplanted human kidney in situ shows altered metabolism in rejection and acute tubular necrosis. J Magn Reson Imaging 7:858-864, 1997
31. Perseghin G, Fiorina P, De Cobelli F, Scifo P, Esposito A, Canu T, Danna M, Gremizzi C, Secchi A, Luzi L, Del Maschio A: Cross-sectional assessment of the effect of kidney and KP transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study. J Am Coll Cardiol 46:1085-1092, 2005
32. Becker BN, Brazy PC, Becker YT, Odorico JS, Pintar TJ, Collins BH, Pirsch JD, Leverson GE, Heisey DM, Sollinger HW: Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 57:2129-2135, 2000
33. Grist TM, Charles HC, Sostman HD: 1990 ARRS Executive Council Award: renal transplant rejection: diagnosis with 31P MR spectroscopy. AJR Am J Roentgenol 156:105-112, 1991
34. Bilous RW, Mauer SM, Sutherland DE, Najarian JS, Goetz FC, Steffes MW: The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 321:80-85, 1989